Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Acute Kidney Injury
19%
Adriamycin
14%
Albuminuria
15%
Arteriovenous Fistula
16%
Asia
15%
Balloon Angioplasty
16%
Chronic Kidney Disease
34%
Chronic Kidney Disease Patients
33%
Constipation
10%
Diabetic Kidney Disease
25%
Dialysis
29%
Double-blind Randomized Controlled Trial
9%
Etiology
9%
Fibroblast Growth Factor 23 (FGF23)
16%
General Hospital
11%
Glomerular Disease
10%
Glomerulus
10%
Hematuria
10%
Hemodialysis
38%
Hemodialysis Patients
25%
Hepatitis C
16%
Hypertension
23%
Indonesia
51%
Indonesian
14%
Indonesian Population
10%
Intensive Care Unit Patients
10%
International Society of Nephrology
10%
Jakarta
19%
Kali
13%
Kidney Failure
21%
Kidney Replacement Therapy
14%
Liver Fibrosis
11%
Maintenance Hemodialysis Patients
44%
Nephrin
18%
Nephrology
12%
Nephrosis
10%
Pada
15%
Peritoneal Dialysis
15%
Podocin
19%
Podocyte
17%
Podocyte Injury
10%
Podocytopathy
9%
Quality of Life
25%
Randomized Controlled Trial
16%
Regular Hemodialysis
11%
Renal Replacement Therapy
10%
Risk Factors
23%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
16%
South-East Asia
18%
Type 1 Diabetes Mellitus (T1DM)
12%
Medicine and Dentistry
2 Methyl 5 Trimethylammoniomethyl 1,3 Oxathiolane
8%
Acute Kidney Injury
18%
Albumin
16%
Albuminuria
13%
Arteriovenous Fistula
8%
Awareness
9%
Calcitriol
8%
Cardiology
8%
Cardiovascular System
18%
Chronic Kidney Disease
38%
Clinician
8%
COVID-19
20%
Creatinine
16%
Cross Sectional Study
17%
Diabetes Mellitus
9%
Diabetic Nephropathy
23%
Diagnostic Accuracy
8%
Disease Exacerbation
13%
Doxorubicin
14%
End Stage Renal Disease
14%
Fibroblast Growth Factor 23
16%
Glomerular Filtration Rate
10%
Glomerulopathy
16%
Glomerulus Filtration
8%
Health Care Cost
13%
Hematuria
10%
Hemodialysis
34%
Lupus Nephritis
9%
Maturity Onset Diabetes of the Young
11%
Nephrin
25%
Nephrologist
9%
Nephrology
23%
Nephropathy
8%
Osmotic Nephrosis
10%
Outpatient
12%
Percutaneous Transluminal Angioplasty
8%
Peritoneal Dialysis
16%
Podocin
25%
Podocyte
23%
Posturography
8%
Prevalence
12%
QT Dispersion
8%
Quality of Life
8%
Randomized Controlled Trial
9%
Renal Biopsy
11%
Renal Failure
30%
Renal Replacement Therapy
27%
Retrospective Cohort Study
9%
Septic Shock
8%
Urinary System
20%
Pharmacology, Toxicology and Pharmaceutical Science
6 N,n' Dimethylarginine
16%
Adriamycin-Induced Nephropathy
8%
Albumin
9%
Albuminuria
9%
Binding Protein
8%
C Reactive Protein
8%
Calcitriol
8%
Calcium Carbonate
8%
Campylobacter Enteritis
8%
Chronic Hepatitis C
8%
Chronic Kidney Failure
52%
Constipation
9%
Creatinine
8%
Cross-Sectional Study
20%
Cross-Sectional Study
11%
Diabetes Mellitus
11%
Diabetic Nephropathy
34%
Disease Exacerbation
13%
Doxorubicin
10%
End Stage Renal Disease
21%
Endotoxin
8%
Fibroblast Growth Factor 23
16%
Focal Glomerulosclerosis
8%
Folic Acid
8%
Frailty
8%
Glomerulopathy
10%
Hematuria
8%
Hemodialysis
100%
Hepatitis C
16%
Homocysteine
8%
Infection
11%
Iron
11%
Khellin
8%
Kidney Failure
8%
Liver Cirrhosis
12%
Liver Fibrosis
16%
Major Adverse Cardiac Event
8%
Maturity Onset Diabetes of the Young
11%
Midazolam
8%
N(g),n(g) Dimethylarginine
16%
Nephrin
21%
Nephritis
8%
Placebo
11%
Podocin
19%
Prevalence
16%
Randomized Controlled Trial
26%
Replacement Therapy
8%
Uric Acid
8%
Vitamin B12
8%
Vitamin D Receptor
8%
